Company Filing History:
Years Active: 2018
Title: Innovations in Immunology: The Contributions of Alejandro Olvera Rodríguez
Introduction
Alejandro Olvera Rodríguez is a prominent inventor based in Morelos, Mexico. He has made significant contributions to the field of immunology, particularly through his innovative work on monoclonal antibodies. His research focuses on enhancing immune responses in various species, including chickens and pigs.
Latest Patents
Rodríguez holds a patent for "Monoclonal antibodies against the DEC-205 receptor of chicken dendritic cells." This invention involves the production and characterization of new murine monoclonal antibodies that specifically recognize the domain CTDL-2 of the DEC-205 receptor found in dendritic cells. The antibodies have the potential to modulate immune responses and are particularly effective in generating a specific humoral immune response against the Hemaglutinina H5 of the H5N2-type avian flu virus.
Career Highlights
Rodríguez is affiliated with the Universidad Nacional Autónoma de México, where he continues to advance research in immunology. His work has implications for both veterinary and human medicine, showcasing the versatility of his inventions.
Collaborations
He has collaborated with notable colleagues, including Lourival Domingos Possani Postay and María Martha Pedraza Escalona. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Alejandro Olvera Rodríguez's contributions to the field of immunology through his patent on monoclonal antibodies highlight the importance of innovation in addressing health challenges. His work exemplifies the potential of scientific research to improve immune responses in various species.